|
|
|
| Trends in incidence of thyroid cancer in Huangpu District from 2002 to 2017 |
| QIU Fengqian, DU Juan, JI Yunfang, GAO Shuna, HE Lihua, LING Qing, ZHANG Yan
|
| Department of Chronic Diseases Control and Prevention, Huangpu Center for Disease Control and Prevention, Shanghai 200023, China |
|
|
|
|
Abstract Objective To analyze the trends in incidence of thyroid cancer in Huangpu District, Shanghai from 2002 to 2017, so as to provide insights into the management of thyroid cancer. Methods The incidence of thyroid cancer in Shanghai from 2002 to 2017 was collected from the cancer registration system created by Shanghai Center for Disease Control and Prevention. The crude and standardized incidence of thyroid cancer were estimated by year, gender and age groups, and annual change percentage ( APC ) was calculated to analyze the trends in incidence of thyroid cancer. Results A total of 2 854 new cases of thyroid cancer were reported in Huangpu District from 2002 to 2017, and the crude and standardized incidence rates of thyroid cancer were 19.57/105 and 13.47/105, with APC of 18.15% and 17.93% ( P<0.05 ), respectively. The crude and standardized incidence rates of thyroid cancer were 10.02/105 and 7.06/105 in men, with APC of 19.58% and 19.04% ( P<0.05 ), and were 28.90/105 and 19.95/105 in women, with APC of 17.33% and 16.99% ( P<0.05 ), respectively. The crude incidence of thyroid cancer was higher in women than in men ( P<0.05 ). In addition, there were two peaks in the crude incidence of thyroid cancer in patients at age of 35 to 39 and 60 to 64 years, with crude incidence rates of 28.98/105 and 33.36/105, respectively. Conclusions The incidence of thyroid cancer appeared a tendency towards a rise in Huangpu District from 2002 to 2017, and much attention should be paid to females and patients aged 60 to 64 years.
|
|
Received: 07 September 2021
Revised: 08 November 2021
Published: 12 January 2022
|
|
|
|
|
|
[1] BRAY F,FERLAY J,SOERJOMTARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2] CHEN W Q,ZHENG R S,BAADE P D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[3] STEWART B,WILD C.World cancer report 2014[M].Lyon:IARC Press,2014:738-750.
[4] 鲍萍萍,吴春晓.上海市癌症流行现况和防治实践[J].上海预防医学,2020,32(11):955-962.
BAO P P,WU C X.Epidemiology,control and prevention of cancers in Shanghai[J].Shanghai J Prev Med,2020,32(11):955-962.
[5] 张洁,闫贻忠,王丹,等.2005—2014年中国肿瘤登记地区甲状腺癌发病的时间趋势分析[J].现代预防医学,2020,47(4):577-582.
ZHANG J,YAN Y Z,WANG D,et al.Time trend analysis of thyroid cancer in tumor registration of China from 2005 to 2014[J].Mod Prev Med,2020,47(4):577-582.
[6] 向芳,黄芳,张一英,等.2003—2013年上海市嘉定区甲状腺癌发病率变化趋势分析[J].中华预防医学杂志,2016,50(7):656-658.
XIANG F,HUANG F,ZHANG Y Y,et al.Trend in incidence of thyroid cancer in Jiading District of Shanghai,2003-2013[J].Chin J Prev Med,2016,50(7):656-658.
[7] 国家癌症中心.2018年中国肿瘤登记年报[M].北京:人民卫生出版社,2019:178-182.
National Cancer Center.China cancer registry annual report in 2018[M].Beijing:People's Medical Publishing House,2019:178-182.
[8] 李伟伟,周金意,董建梅,等.2015年江苏省甲状腺癌流行现状及2006—2015年趋势分析[J].实用肿瘤学杂志,2021,35(1):1-6.
LI W W,ZHOU J Y,DONG J M,et al.Epidemic status of thyroid cancer in Jiangsu province in 2015 and its trend analysis from 2006 to 2015[J].Pract Oncol J,2021,35(1):1-6.
[9] 郑文龙,张爽,沈成凤,等.天津市2010—2014年甲状腺癌流行特征及长期发病和死亡趋势分析[J].中国肿瘤,2018,27(9):670-674.
ZHENG W L,ZHANG S,SHEN C F,et al.Epidemiological characteristics and long-term trends of thyroid cancer in Tianjin[J].China Cancer,2018,27(9):670-674.
[10] 雷林,尚庆刚,刘秋耿,等.深圳市2001—2015年甲状腺癌发病现状和趋势分析[J].中国肿瘤,2019,28(7):504-508.
LEI L,SHANG Q G,LIU Q G,et al.Incidences and epidemiologic trends of thyroid cancer in Shenzhen,2001-2015[J].China Cancer,2019,28(7):504-508.
[11] 鲍萍萍,吴春晓,张敏璐,等.2015年上海市恶性肿瘤流行特征分析[J].中国癌症杂志,2019,29(2):81-99.
BAO P P,WU C X,ZHANG M L,et al.Report of cancer epidemiology in Shanghai,2015[J].Chin Oncol,2019,29(2):81-99.
[12] 滕卫平. 我国面临甲状腺癌“过度诊断”的挑战[J].中华内分泌代谢杂志,2016,32(7):531-532.
TENG W P.We are facing a challenge of “overdiagnosis” of the thyroid cancer[J].Chin J Endocrinol Metab,2016,32(7):531-532.
[13] BRAY F,FERLAY J,SOERJOMTARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[14] 谢林宏,黄恒艺,钟贤君.中国甲状腺癌发病趋势[J].世界最新医学信息文摘,2019,19(60):44-45.
XIE L H, HUANG H Y,ZHONG X J.Exploring the incidence trend of thyroid cancer in China[J].World Latest Med Inf,2019,19(60):44-45.
[15] 张璐,刘跃武.雌激素与甲状腺癌的关系[J].基础医学与临床,2010,30(7):782-784.
ZHANG L,LIU Y W.The relationship between estrogen and thyroid carcinoma[J].Basic Clin Med,2010,30(7):782-784.
[16] ZANE M,PARELLO C,PENNELLI G,et al.Estrogen and thyroidcancer is a stem affair:a preliminary study[J].Biomed Pharmacother,2017,85:399-411.
[17] 应可明,陈峥,燕归如,等.34例医务人员放射性甲状腺疾病临床特征分析[J].中国医药导刊,2018,20(5):265-270.
YING K M,CHEN Z,YAN G R,et al.Clinical characteristics analysis of 34 cases of radiation thyroid diseases of medical personnel[J].Chin J Med Guide,2018,20(5):265-270.
[18] 胡锦峰,傅容.杭州市城区居民甲状腺癌发病趋势分析[J].浙江预防医学,2016,28(3):244-246,255.
HU J F,FU R.An analysis on the trend of thyroid cancer incidence among urban residents in Hangzhou City[J].Zhejiang J Prev Med,2016,28(3):244-246,255.
[19] 陈万青,郑荣寿,张思维,等.2013年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2017,26(1):1-7.
CHEN W Q,ZHENG R S,ZHANG S W,et al.Report of cancer incidence and mortality in China,2013[J].China Cancer,2017,26(1):1-7. |
|
|
|
